Clinical trial
Artificial Intelligence-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary Computer Tomography Angiography
NCT06748261 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Artificial Intelligence-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary Computer Tomography Angiography
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 30, 2024
- Completion date
- December 30, 2025
- Enrollment
- 5,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
amyloid cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, cardiomyopathies, cardiovascular diseases, dilated cardiomyopathy (dcm), hypertrophic cardiomyopathy (hcm), ischemic cardiomyopathy, myocarditis, restrictive cardiomyopathy